Rectal cancer can still accept _'s general knowledge of radiotherapy again while recuring

Rectal cancer can still accept _'s general knowledge of radiotherapy again while recuring
A research that is published on the cancer magazine indicates, can still accept heavy dose of radiotherapy after rectal cancer recurs, this treatment will not bring too great risk and serious side effect.

Dr. Mohammed Mohiuddin of the medical center of U.S.A. Kentucky university points out, because of worrying causing damaging to normal local organization, rectal cancer seldom adopts some radiotherapy again after recuring.

For study result of radiotherapy again, researcher choose recur patient by 103 the intersection of rectum and the intersection of gland and cancer, adopt radiotherapy and based on 5 Fluorine urine pyrimidine chemotherapy again, after radiotherapy, 34 can perform the operation and excise moreover.

Found finally, the average existence time of the person who treats future trouble was 26 months, survival rate was 19% in total 5. Survival rate is 44 months and 22% respectively the average existence time and 5 of the persons who perform the operation again, only accept survival rate is 15% the radiotherapy patient's average existence time and 5.

Researchers point out, though 22% of the patients acute radiotherapy chemotherapy toxicity take place and react and stop or stop treating temporarily, generally speaking, the healing solution is easy to tolerate. In addition, have not seen the prominent difference in complication incidence of every radiotherapy dosage.

nbspMohiuddin doctor thinks, rectal cancer patient that the part recured again after for treating, can improve its quality of surviving for the radiotherapy again, some patients can even obtain the chance to perform the operation again.
|